IHH Healthcare Bhd(MY:5225)
RM7.73-0.01 (-0.13%)
MY:5225
IHH Healthcare Bhd financials statements
RM7.73
At close:-0.01 (-0.13%)
IHH Healthcare Bhd (5225) Ratios
IHH Healthcare Bhd Ratios
MY:5225's free cash flow for Q2 2026 was RM497.00M. For the 2026 fiscal year, MY:5225's free cash flow was decreased by RM-813.00M and operating cash flow was RM1.31B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.58 | 0.72 | 0.90 | 1.14 | 1.41 |
| Quick Ratio | 0.51 | 0.64 | 0.80 | 1.06 | 1.32 |
| Cash Ratio | 0.14 | 0.16 | 0.32 | 0.25 | 0.83 |
| Solvency Ratio | 0.17 | 0.19 | 0.24 | 0.15 | 0.17 |
| Operating Cash Flow Ratio | 0.44 | 0.45 | 0.50 | 0.51 | 0.58 |
| Short-Term Operating Cash Flow Coverage | 0.89 | 1.18 | 2.16 | 2.24 | 2.80 |
| Net Current Asset Value | RM -16.86B | RM -15.98B | RM -12.18B | RM -11.03B | RM -9.70B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.26 | 0.20 | 0.22 | 0.24 |
| Debt-to-Equity Ratio | 0.51 | 0.49 | 0.35 | 0.41 | 0.44 |
| Debt-to-Capital Ratio | 0.34 | 0.33 | 0.26 | 0.29 | 0.31 |
| Long-Term Debt-to-Capital Ratio | 0.20 | 0.24 | 0.19 | 0.22 | 0.24 |
| Financial Leverage Ratio | 1.90 | 1.88 | 1.76 | 1.85 | 1.85 |
| Debt Service Coverage Ratio | 0.66 | 1.28 | 2.25 | 1.67 | 2.31 |
| Interest Coverage Ratio | 3.15 | 5.12 | 5.56 | 5.70 | 7.06 |
| Debt to Market Cap | 0.17 | 0.28 | 0.17 | 0.18 | 0.15 |
| Interest Debt Per Share | 1.88 | 1.77 | 1.23 | 1.28 | 1.29 |
| Net Debt to EBITDA | 2.66 | 2.11 | 1.23 | 2.20 | 1.36 |
| Profitability Margins | |||||
| Gross Profit Margin | 25.74% | 72.03% | 70.20% | 69.44% | 69.99% |
| EBIT Margin | 13.02% | 18.63% | 22.63% | 14.95% | 17.52% |
| EBITDA Margin | 20.35% | 25.74% | 29.85% | 22.77% | 25.18% |
| Operating Profit Margin | 13.02% | 16.53% | 19.86% | 14.95% | 18.32% |
| Pretax Profit Margin | 13.32% | 15.40% | 19.34% | 12.32% | 14.92% |
| Net Profit Margin | 8.16% | 10.90% | 14.10% | 8.61% | 10.87% |
| Continuous Operations Profit Margin | 10.13% | 12.97% | 16.20% | 9.15% | 12.71% |
| Net Income Per EBT | 61.29% | 70.74% | 72.90% | 69.84% | 72.88% |
| EBT Per EBIT | 102.30% | 93.20% | 97.39% | 82.46% | 81.45% |
| Return on Assets (ROA) | 3.65% | 4.68% | 5.76% | 3.19% | 4.09% |
| Return on Equity (ROE) | 6.93% | 8.82% | 10.14% | 5.91% | 7.58% |
| Return on Capital Employed (ROCE) | 7.25% | 8.54% | 9.49% | 6.52% | 7.95% |
| Return on Invested Capital (ROIC) | 4.89% | 6.64% | 7.61% | 4.63% | 6.53% |
| Return on Tangible Assets | 5.51% | 7.21% | 8.68% | 4.76% | 5.95% |
| Earnings Yield | 2.72% | 5.67% | 6.14% | 2.98% | 3.16% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.24 | 8.18 | 150.69 | 7.67 | 7.15 |
| Payables Turnover | 3.87 | 1.33 | 3.20 | 3.15 | 3.39 |
| Inventory Turnover | 23.93 | 8.96 | 8.67 | 9.23 | 9.72 |
| Fixed Asset Turnover | 1.01 | 1.03 | 1.02 | 0.97 | 0.99 |
| Asset Turnover | 0.45 | 0.43 | 0.41 | 0.37 | 0.38 |
| Working Capital Turnover Ratio | -6.92 | -14.14 | 149.70 | 10.26 | 8.13 |
| Cash Conversion Cycle | -28.62 | -189.12 | -69.39 | -28.57 | -18.97 |
| Days of Sales Outstanding | 50.42 | 44.59 | 2.42 | 47.58 | 51.07 |
| Days of Inventory Outstanding | 15.25 | 40.73 | 42.09 | 39.56 | 37.56 |
| Days of Payables Outstanding | 94.29 | 274.45 | 113.91 | 115.71 | 107.61 |
| Operating Cycle | 65.67 | 85.32 | 44.52 | 87.15 | 88.64 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.57 | 0.49 | 0.43 | 0.42 | 0.40 |
| Free Cash Flow Per Share | 0.18 | 0.12 | 0.21 | 0.22 | 0.28 |
| Dividend Paid and CapEx Coverage Ratio | 1.16 | 1.04 | 1.01 | 1.63 | 2.48 |
| Capital Expenditure Coverage Ratio | 1.47 | 1.32 | 1.93 | 2.14 | 3.30 |
| Operating Cash Flow Coverage Ratio | 0.33 | 0.29 | 0.37 | 0.34 | 0.32 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.18 | 0.18 | 0.20 | 0.21 |
| Free Cash Flow Yield | 2.08% | 2.23% | 3.78% | 3.76% | 4.18% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 36.46 | 17.72 | 16.29 | 33.52 | 31.61 |
| Price-to-Sales (P/S) Ratio | 3.00 | 1.92 | 2.30 | 2.89 | 3.44 |
| Price-to-Book (P/B) Ratio | 2.55 | 1.55 | 1.65 | 1.98 | 2.39 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 48.13 | 44.77 | 26.49 | 26.60 | 23.92 |
| Price-to-Operating Cash Flow Ratio | 15.29 | 10.93 | 12.79 | 14.15 | 16.67 |
| Price-to-Earnings Growth (PEG) Ratio | -1.82 | -1.51 | 0.16 | -2.23 | 0.04 |
| Enterprise Value Multiple | 17.40 | 9.57 | 8.93 | 14.87 | 15.01 |
| Enterprise Value | 91.19B | 60.10B | 55.79B | 60.91B | 64.73B |
| EV to EBITDA | 17.40 | 9.57 | 8.93 | 14.87 | 15.01 |
| EV to Sales | 3.54 | 2.46 | 2.66 | 3.39 | 3.78 |
| EV to Free Cash Flow | 56.82 | 57.46 | 30.72 | 31.21 | 26.30 |
| EV to Operating Cash Flow | 18.05 | 14.03 | 14.84 | 16.61 | 18.33 |
| Tangible Book Value Per Share | 1.66 | 1.59 | 1.71 | 1.50 | 1.49 |
| Shareholders’ Equity Per Share | 3.43 | 3.42 | 3.30 | 2.98 | 2.80 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.16 | 0.16 | 0.26 | 0.15 |
| Revenue Per Share | 2.92 | 2.77 | 2.38 | 2.04 | 1.95 |
| Net Income Per Share | 0.24 | 0.30 | 0.34 | 0.18 | 0.21 |
| Tax Burden | 0.61 | 0.71 | 0.73 | 0.70 | 0.73 |
| Interest Burden | 1.02 | 0.83 | 0.85 | 0.82 | 0.85 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.13 | 0.01 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.40 | 1.14 | 1.27 | 1.65 | 1.38 |
Currency in MYR
